Webinar | May 3, 2021

Clinical Strategy For Successful Cell And Gene Therapy — How Did I Get Here?

Source: Cytiva

More than a thousand regenerative medicine clinical trials are underway globally, of which more than 40% are for cell therapies targeting cancer. Cell therapies have the potential to transform global healthcare by providing curative therapies for once incurable diseases. There are major challenges to the widespread adoption of cell therapies, primarily related to the high manufacturing costs of what is largely a manual process with complex logistics and supply chain.

Experts share their experiences and discuss emerging trends in the field to accelerate life-saving therapies from the bench to the bedside.

Dr. Wilson Bryan, director at the Office of Tissues and Advanced Therapies, FDA
Dr. Alison Moore, Chief Technology Officer at Allogene Therapeutics
Dr. Hari Pujar, operating partner at Flagship Pioneering
Dr. Greg Russotti, Chief Technology Officer at Century Therapeutics

Moderated by: Dr. Dolores Baksh, global solutions marketing leader for Cytiva’s cell therapy business

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online